Patents by Inventor Joseph P. Arena

Joseph P. Arena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030166144
    Abstract: Human, swine and rat growth hormone secretagogue receptors have been isolated, cloned and sequenced. Growth hormone secretagogue receptors are new members of the G-protein family of receptors. The growth hormone secretagogue receptors may be used to screen and identify compounds which bind to the growth hormone secretagogue receptor. Such compounds may be used in the treatment of conditions which occur when there is a shortage of growth hormone, such as observed in growth hormone deficient children, elderly patients with musculoskeletal impairment and recovering from hip fracture and osteoporosis.
    Type: Application
    Filed: November 25, 2002
    Publication date: September 4, 2003
    Applicant: Merck & Co., Inc.
    Inventors: Joseph P. Arena, Doris F. Cully, Scott D. Feighner, Andrew D. Howard, Paul A. Liberator, James M. Schaeffer, Leonardus H. T. Van Der Ploeg
  • Patent number: 6531314
    Abstract: Human, swine and rat growth hormone secretagogue receptors have been isolated, cloned and sequenced. Growth hormone secretagogue receptors are new members of the G-protein family of receptors. The growth hormone secretagogue receptors may be used to screen and identify compounds which bind to the growth hormone secretagogue receptor. Such compounds may be used in the treatment of conditions which occur when there is a shortage of growth hormone, such as observed in growth hormone deficient children, elderly patients with musculoskeletal impairment and recovering from hip fracture and osteoporosis.
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: March 11, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Joseph P. Arena, Doris F. Cully, Scott D. Feighner, Andrew D. Howard, Paul A. Liberator, James M. Schaeffer, Leonardus H. T. Van Der Ploeg
  • Patent number: 5693492
    Abstract: DNA encoding glutamate and avermectin-sensitive chloride channels have been cloned and characterized. The protein is capable of forming channels selectively opened with either avermectin or glutamate. The cDNA has been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified. Receptor modulators active in the method disclosed herein are useful as ectoparasiticides, antiparasitic, anthelmenthic, acaracidal and insecticide agents.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: December 2, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Doris F. Cully, Joseph P. Arena, Philip S. Paress, Ken K. Liu
  • Patent number: 5688917
    Abstract: DNAs encoding voltage-activated cation channels have been cloned and characterized. The cDNA's have been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells.
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: November 18, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Joseph P. Arena, Guoping Feng, Linda M. Hall, Ken Liu, Leonardus H. T. Van Der Ploeg, Peiyi Wang, Jeffrey W. Warmke
  • Patent number: 5593864
    Abstract: DNAs encoding voltage-activated cation channels have been cloned and characterized. The cDNA's have been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells.
    Type: Grant
    Filed: November 10, 1994
    Date of Patent: January 14, 1997
    Assignees: Merck & Co., Inc., The Research Foundation of State University of New York
    Inventors: Joseph P. Arena, Guoping Feng, Linda M. Hall, Ken Liu, Leonardus H. T. Van Der Ploeg, Peiyi Wang, Jeffrey W. Warmke
  • Patent number: 5527703
    Abstract: DNAs encoding glutamate and avermectin-sensitive chloride channels have been cloned and characterized. The individual alpha and beta subunits are capable of forming homomeric and heteromeric channels selectively opened with either avermectin or glutamate. The cDNA's have been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified. Receptor modulators are useful as insecticides and anthelminthic agents.
    Type: Grant
    Filed: May 25, 1994
    Date of Patent: June 18, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Doris F. Cully, Joseph P. Arena, Ken K. Liu, Demetrios Vassilatis
  • Patent number: 4316493
    Abstract: Vertical blinds having commonly housed and traversely movable controls for controlling the traverse and rotation of the vanes are disclosed. In a disclosed embodiment, the vanes are supported by carrier members, and a rotation rod extends through the carrier members. The carrier members are slideable along the rotation rod. A control assembly is mounted to slide along and also rotate the rotation rod. Sliding of the control assembly along the rotation rod slides the carrier members to thereby traverse the vanes, and actuation of the control assembly rotates the rotation rod and the vanes. The control assembly includes meshing bevel gears, one of which is coupled to an actuating rod or wand and the other to the rotation rod whereby rotation of the wand causes rotation of the vanes. The control assembly is slid by means of the wand which is universally connected to the control assembly. The wand is thus a unitary control for actuating both traverse and rotation of the vanes.
    Type: Grant
    Filed: August 15, 1977
    Date of Patent: February 23, 1982
    Inventor: Joseph P. Arena
  • Patent number: 4293021
    Abstract: A support member for horizontal members or elements in a traversable opening covering device is disclosed. In the preferred embodiment, the opening covering device is a vertical blind for a window opening. The vertical blind includes a plurality of vanes and carriers supporting the vanes, and a track structure for traversably supporting the carriers. The rod controls movement of the vanes, i.e. traversing or rotating of the vanes. In the preferred embodiment, the carriers are traversed by a cord arrangement and the support member also supports the cord.
    Type: Grant
    Filed: June 6, 1979
    Date of Patent: October 6, 1981
    Inventor: Joseph P. Arena
  • Patent number: 4140169
    Abstract: A unitary, one-piece vane carrier for vertical blinds is disclosed. The unitary carrier includes a carrier body and an elongated spacer link extending from one end of the body, the spacer link and body forming a single, unitary piece. In a disclosed embodiment, a tab is disposed at the distal end of the spacer link and a slotted opening is located in the end of the carrier body opposed to the end from which the spacer link extends. In that embodiment, the tab of one carrier cooperates with the slotted opening of an adjacently positioned carrier to limit the maximum spacing between the two carriers. The spacer link extends from the top of one end of the carrier body while the slotted opening is oppositely located at the top of the other end such that the spacer link of one carrier is slidable through the slotted opening of the adjacent carrier.
    Type: Grant
    Filed: August 15, 1977
    Date of Patent: February 20, 1979
    Inventor: Joseph P. Arena